Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

2 months ago 37
The acquisition brings a caller attack to treating allergic diseases to the company’s immunology pipeline.
Read Entire Article
  1. Homepage
  2. Technology
  3. Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

Related

SpaceX Stock Rises 11% in Largest IPO Ever

SpaceX Stock Rises 11% in Largest IPO Ever

1 hour ago 0
If You Have a 401(k), How Much SpaceX Stock Will You Own?

If You Have a 401(k), How Much SpaceX Stock Will You Own?

1 hour ago 1
Elon Musk Becomes World’s First Trillionaire as SpaceX Stock Begins Trading

Elon Musk Becomes World’s First Trillionaire as SpaceX Stock...

2 hours ago 1

Popular

Democratic candidate for U.S. Senate Graham Platner held a town hall where voters could ask him about allegations of past misconduct. No one did. Instead, voters doubled down on support for him.

Democratic candidate for U.S. Senate Graham Platner held a t...

4 days ago 12
Surgeons use new AI tool during live operation in UK-first

Surgeons use new AI tool during live operation in UK-first

6 days ago 11
Changes to lymph nodes 'could identify who is most at cancer risk'

Changes to lymph nodes 'could identify who is most at cancer...

6 days ago 10
‘Liberation,’ about a consciousness-raising women’s group in the 1970s, wins the Tony Award for best new play

‘Liberation,’ about a consciousness-raising women’s group in...

4 days ago 10
ANWR Oil Draws Few Bids, Despite Trump’s Push for ‘Liquid Gold’

ANWR Oil Draws Few Bids, Despite Trump’s Push for ‘Liquid Go...

6 days ago 9
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved